Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-005569 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
149.40% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.95% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
32.93% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
126.10% · CORE · VALID
Inventory pressure 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
1.04% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
86.33% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
25.47% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.46% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 79.31%
Current 149.40%
Delta 70.09% Capex Intensity Decreased
Previous 5.70%
Current 1.95%
Delta -3.75% Cash Generation Increased
Previous 24.30%
Current 32.93%
Delta 8.63% Growth Increased
Previous -24.05%
Current 126.10%
Delta 150.15% Inventory Pressure Increased
Previous 0.44%
Current 1.04%
Delta 0.61% Margin Increased
Previous 72.74%
Current 86.33%
Delta 13.60% Profitability Increased
Previous -0.91%
Current 25.47%
Delta 26.38% R And D Intensity Decreased
Previous 38.83%
Current 21.46%
Delta -17.36% Sbc Intensity Decreased
Previous 10.86%
Current 4.64%
Delta -6.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.